Pharmaniaga Berhad operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaniaga Berhad with three other
drug stores in Asia:
Zhejiang Zhenyuan Co., Ltd.
sales of 2.44 billion Chinese Renmimbi [US$367.64 million]
of which 84%
was Medicine Wholesales),
Jiangsu Nhwa Pharmaceutical Company Limited
(3.02 billion Chinese Renmimbi [US$454.67 million]
of which 55%
was Medical Industrial Manufacturing), and
Chuangmei Pharmaceutical Co Ltd
based in Hong Kong
(4.28 billion Hong Kong Dollars [US$548.53 million]
During the year ended December of 2016, sales at
Pharmaniaga Berhad were 2.19 billion Malaysian Ringgits (US$521.95 million).
decrease of 0.0%
versus 2015, when the company's sales were 2.19 billion Malaysian Ringgits.
Contributing to the drop in overall sales was the 0.7% decline
in Operating Segment- Logistics and Distrib, from 2.17 billion Malaysian Ringgits to 2.15 billion Malaysian Ringgits.
However, these declines were partially offset by the increase in sales of
Opearting Segment- Manufacturing (up 70.5% to 36.49 million Malaysian Ringgits)